Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction
Comparing the Efficacy of Combined Behavioral Intervention and Ericksonian Hypnotherapy in the Treatment of Alcohol Addiction: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
This clinical study is being conducted to compare the effectiveness of two psychological treatments for alcohol addiction: Combined Behavioral Intervention (CBI) and Ericksonian Hypnotherapy (EH). The purpose of the study is to determine whether Ericksonian Hypnotherapy, a more personalized and indirect therapeutic method, is equal to or more effective than the gold-standard approach, Combined Behavioral Intervention, in helping individuals reduce their alcohol consumption and improve psychological well-being. Alcohol addiction is a serious condition that affects mental, emotional, and physical health. Many treatment options exist, but not all individuals respond in the same way. This study aims to evaluate two different types of therapy in a structured way, to better understand which works best, for whom, and under what circumstances. The study will include 90 adult participants diagnosed with Alcohol Use Disorder (AUD). Participants will be randomly assigned to one of three groups: (1) a group receiving weekly sessions of Combined Behavioral Intervention, (2) a group receiving weekly sessions of Ericksonian Hypnotherapy, or (3) a control group receiving general educational materials about alcohol addiction. Treatment will last for 12 weeks, and all participants will be followed up three months after the last session to assess long-term effects. Throughout the study, researchers will measure changes in alcohol consumption, alcohol craving, mental health symptoms (such as depression and anxiety), quality of life, and motivation to change. The findings of this study may help improve the way alcohol addiction is treated by offering evidence on alternative approaches such as hypnotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedApril 16, 2025
April 1, 2025
9 months
April 1, 2025
April 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Alcohol Consumption (TLFB)
Self-reported alcohol consumption measured using the Timeline Follow-Back (TLFB) method. TLFB assesses the number of standard drinks consumed each day over the past 30 days. Higher scores indicate greater alcohol use. A reduction in total drinks consumed per month represents clinical improvement.
Baseline to Week 6, Week 12, and Month 10 (3-Month Follow-Up)
Secondary Outcomes (6)
Change in Craving Beliefs (CBQ)
Baseline to Week 6, Week 12, and Week 24
Change in Craving Typologies (CTQ)
Baseline to Week 6, Week 12, and Week 24
Change in Depression Symptoms (BDI-II)
Baseline to Week 6, Week 12, and Week 24
Change in Anxiety Symptoms (BAI)
Baseline to Week 6, Week 12, and Week 24
Change in Quality of Life (WHOQOL-BREF)
Baseline to Week 6, Week 12, and Week 24
- +1 more secondary outcomes
Study Arms (3)
Combined Behavioral Intervention (CBI)
EXPERIMENTALParticipants in this arm will receive a manualized Combined Behavioral Intervention consisting of 12 weekly sessions, each approximately 60 minutes. The intervention includes elements of Motivational Interviewing, Cognitive Behavioral Therapy, and relapse prevention strategies. Sessions are delivered either individually by licensed therapists trained in behavioral therapy.
Ericksonian Hypnotherapy (EH)
EXPERIMENTALParticipants in this arm will receive Ericksonian Hypnotherapy in 12 weekly individual sessions, each approximately 45-60 minutes. The intervention uses personalized trance induction, metaphorical storytelling, ego-strengthening, and post-hypnotic suggestions.
Control (Standard Care Information)
NO INTERVENTIONParticipants in this group will not receive structured psychotherapy but will be provided with psychoeducational brochures and referral resources related to alcohol addiction treatment. They will complete the same assessment schedule as the other groups.
Interventions
The intervention includes 12 weekly sessions integrating Motivational Interviewing, Cognitive Behavioral Therapy, and relapse prevention strategies. Techniques include enhancing motivation to change, identifying cognitive distortions, managing high-risk situations, and developing alternative coping strategies.
This therapy includes 12 weekly sessions involving individualized trance induction, indirect suggestion, therapeutic metaphor, and ego-strengthening techniques. The sessions follow Ericksonian principles and are delivered by certified hypnotherapists.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 65 years
- Meets DSM-5 diagnostic criteria for Alcohol Use Disorder (mild to severe)
- Medically and psychiatrically stable as determined by a clinician
- Willing and able to participate in weekly sessions over a 12-week period
- Provides informed consent
You may not qualify if:
- Current diagnosis of a severe psychiatric disorder (e.g., psychotic disorder, bipolar I disorder)
- Significant cognitive impairment that would interfere with treatment participation
- Participation in another structured addiction treatment during the study period
- Current use of psychotropic medications that may influence outcome measures (as assessed by the clinical team)
- Unstable medical condition requiring immediate intervention
- Pregnancy or planning to become pregnant during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beykoz Universitylead
- Istanbul Nisantasi Universitycollaborator
- Uskudar Universitycollaborator
Study Sites (1)
Beykoz University
Istanbul, 34820, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gökben Hızlı Sayar, Prof
Üsküdar University
- STUDY DIRECTOR
Selami Varol Ülker, Phd
Üsküdar University
- PRINCIPAL INVESTIGATOR
Metin Çınaroğlu, Phd
Istanbul Nisantasi University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors who collect follow-up and post-treatment data will be blinded to participants' group assignment. Participants and therapists are not blinded due to the nature of behavioral interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 1, 2025
First Posted
April 8, 2025
Study Start
March 1, 2025
Primary Completion
November 15, 2025
Study Completion
February 1, 2026
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- Data will be available upon request starting immediately after the publication of the main study findings in a peer-reviewed journal. Data will remain accessible for 36 months after the date of publication.
- Access Criteria
- Access will be granted to qualified researchers affiliated with academic or non-profit institutions who provide a methodologically sound proposal approved by the study team. Requesters must sign a data use agreement. Access will include de-identified individual participant data and supporting documents. Requests can be submitted via email to the principal investigator following publication.
De-identified individual participant data (IPD) that underlie the results reported in published articles will be shared. This includes data on alcohol use, craving (CBQ and CTQ), depression, anxiety, quality of life, motivation to change, and session attendance. Data will be made available to qualified researchers affiliated with academic or nonprofit institutions upon request and approval. Data will be shared through secure institutional repositories.